DE EN

About us

Sanochemia Diagnostics Deutschland GmbH is a wholly owned subsidiary of the Austrian Sanochemia Pharmazeutika AG and thus part of an R&D oriented international company. Sanochemia Pharmazeutika AG "the Specialty Pharma Company has been listed on the Frankfurt Stock Exchange since 1999 - a significant step of development which was the basis for the growth and present success. This success results from the consequent orientation towards key competences: efficient management and implementation of complex pharmaceutical projects.

Sanochemia Diagnostics has the aim to offer its customers a platform that fulfills the medical need and ensures an economic efficiency. As the diagnostics field is the most dynamic, Sanochemia Diagnostics will exploit these opportunities by further forcing international sales both through the organic growth of existing distribution channels and by penetrating new markets.


Contrast Media - Worldwide

During the last years Sanochemia Diagnostics has grown to be a global player with its own production, and today our products can already be found in many of the most important markets.

The international business is carried out by Sanochemia Diagnostics International Ltd in Zug, Switzerland. Goal of the International Business Department is to develop and maintain a worldwide network consisting of subsidiaries and distributors.

Responsible for the UK market is Sanochemia Diagnostics UK Ltd. The company is managed from the company offices in Bristol.

In the USA Sanochemia Corp. has been founded in 2004. The HIV test Fluorognost® is the market leader among the immunofluorescence assays available in the US and is approved by the FDA for use both in screening and confirmatory testing. Our non ionic contrast media will be licenced in the USA soon.